RHBC
AGN

R.H. Bluestein & Co’s Allergan plc AGN Stock Holding History

R.H. Bluestein & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,248
Closed -$239K – 372
2019
Q4 		$239K Buy
+1,248
New +$225K 0.01% 312
2017
Q4 		– Sell
-3,000
Closed -$615K – 346
2017
Q3 		$615K Hold
3,000
– – 0.03% 134
2017
Q2 		$729K Sell
3,000
-1,000
-25% -$235K 0.04% 94
2017
Q1 		$956K Buy
4,000
+1,999
+100% +$466K 0.06% 81
2016
Q4 		$420K Sell
2,001
-105,950
-98% -$21.9M 0.03% 142
2016
Q3 		$24.9M Buy
107,951
+56,625
+110% +$13.8M 1.64% 33
2016
Q2 		$11.9M Buy
51,326
+48,299
+1,596% +$11.1M 0.91% 35
2016
Q1 		$811K Sell
3,027
-124,984
-98% -$35.8M 0.06% 87
2015
Q4 		$40M Buy
128,011
+4,295
+3% +$1.28M 2.5% 13
2015
Q3 		$33.6M Sell
123,716
-46,665
-27% -$14.3M 2.39% 14
2015
Q2 		$51.7M Sell
170,381
-4,331
-2% -$1.29M 3.14% 3
2015
Q1 		$52M Buy
174,712
+6,194
+4% +$1.77M 3.14% 2
2014
Q4 		$43.4M Buy
168,518
+23,662
+16% +$5.91M 2.71% 3
2014
Q3 		$35M Buy
144,856
+61,146
+73% +$13.7M 2.19% 9
2014
Q2 		$18.7M Buy
+83,710
New +$17.3M 1.11% 41

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

R.H. Bluestein & Co's AGN Position: Q1 2020 in Review

R.H. Bluestein & Co sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 1,248 shares — an estimated $239K sold.

R.H. Bluestein & Co first reported a position in AGN in Q2 2014 and held it in 15 quarters. The position peaked at $52M in Q1 2015. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • R.H. Bluestein & Co reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • R.H. Bluestein & Co sold 1,248 Allergan plc shares in Q1 2020, an estimated $239K.
  • R.H. Bluestein & Co first reported a position in Allergan plc in Q2 2014 and held it in 15 quarters.
  • R.H. Bluestein & Co's Allergan plc position peaked at $52M in Q1 2015.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on R.H. Bluestein & Co's 13F filing for Q1 2020, filed 12 May 2020.